Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

PI3K/AKT pathway inhibitors can lead to hyperglycemia, but you can be ready when or if it happens. Join us for this dynamic, live webinar designed to elevate your skills to prevent and manage hyperglycemia in patients with metastatic HR+/HER2- breast cancer. Discover real-world strategies, using the latest evidence and guideline-based insights, to optimize the use of PI3K/AKT pathway inhibitors while effectively preventing and managing treatment-related hyperglycemia. You'll learn how oncology and endocrinology teams can collaborate seamlessly to overcome real-world challenges and improve patient outcomes. Don't miss this opportunity to engage in interactive case-based discussions that will equip you with practical tools, including downloadable point-of-care resources you can implement immediately.